This supports our hypothesis that the hydrophobic moiety of our molecules interacts with a specific allosteric hydrophobic pocket in protein kinases, justifying the use of bulkier and more lipophilic substituents (larger logP) in order to obtain improved anti-cancer activity (lower IC50 values). The gene discussed is WEE1; the disease is cancer.